$FZMD
Fuse Medical, Inc.

2019 Q1 Form 10-Q Financial Statement

#000156459019016370 Filed on May 07, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q1
Revenue $4.771M $6.000M
YoY Change -20.49% 3949.76%
Cost Of Revenue $1.975M $3.120M
YoY Change -36.69% 6358.42%
Gross Profit $2.795M $2.880M
YoY Change -2.94% 2784.38%
Gross Profit Margin 58.59% 48.0%
Selling, General & Admin $2.364M $2.196M
YoY Change 7.66% 140.15%
% of Gross Profit 84.58% 76.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $25.72K $2.079K
YoY Change 1137.33% -61.12%
% of Gross Profit 0.92% 0.07%
Operating Expenses $2.364M $3.777M
YoY Change -37.41% 23.21%
Operating Profit $431.1K -$896.7K
YoY Change -148.08% 67.18%
Interest Expense $25.44K $35.91K
YoY Change -29.16% 12.39%
% of Operating Profit 5.9%
Other Income/Expense, Net -$25.44K
YoY Change
Pretax Income -$625.5K -$943.4K
YoY Change -33.69% 79.7%
Income Tax -$114.5K -$197.6K
% Of Pretax Income
Net Earnings -$511.0K -$735.0K
YoY Change -30.47% 40.0%
Net Earnings / Revenue -10.71% -12.25%
Basic Earnings Per Share -$0.01 -$0.03
Diluted Earnings Per Share -$7.434K -$25.74K
COMMON SHARES
Basic Shares Outstanding 68.74M 28.36M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $851.8K $800.0K
YoY Change 6.47% 77.78%
Cash & Equivalents $851.8K $797.8K
Short-Term Investments
Other Short-Term Assets $32.22K $30.00K
YoY Change 7.4% 0.0%
Inventory $11.00M $10.25M
Prepaid Expenses
Receivables $3.220M $4.710M
Other Receivables $0.00 $0.00
Total Short-Term Assets $15.10M $15.79M
YoY Change -4.34% 2450.49%
LONG-TERM ASSETS
Property, Plant & Equipment $37.61K $10.00K
YoY Change 276.1% 54.63%
Goodwill
YoY Change
Intangibles $1.268M
YoY Change
Long-Term Investments
YoY Change
Other Assets $886.0K $580.0K
YoY Change 52.76%
Total Long-Term Assets $5.096M $1.420M
YoY Change 258.9% 13701.15%
TOTAL ASSETS
Total Short-Term Assets $15.10M $15.79M
Total Long-Term Assets $5.096M $1.420M
Total Assets $20.20M $17.21M
YoY Change 17.38% 2634.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.518M $1.530M
YoY Change -0.76% 1952.23%
Accrued Expenses $2.354M $2.190M
YoY Change 7.47% 7526.94%
Deferred Revenue
YoY Change
Short-Term Debt $1.547M $2.820M
YoY Change -45.15% 1780.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.419M $6.540M
YoY Change -17.14% 2119.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $13.58M $19.24M
YoY Change -29.41%
Total Long-Term Liabilities $13.58M $19.24M
YoY Change -29.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.419M $6.540M
Total Long-Term Liabilities $13.58M $19.24M
Total Liabilities $19.00M $25.79M
YoY Change -26.33% 8637.07%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $959.3K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.200M -$8.578M
YoY Change
Total Liabilities & Shareholders Equity $20.20M $17.21M
YoY Change 17.38% 2634.41%

Cashflow Statement

Concept 2019 Q1 2018 Q1
OPERATING ACTIVITIES
Net Income -$511.0K -$735.0K
YoY Change -30.47% 40.0%
Depreciation, Depletion And Amortization $25.72K $2.079K
YoY Change 1137.33% -61.12%
Cash From Operating Activities $88.01K $734.7K
YoY Change -88.02% -0.72%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -80.58K -741.6K
YoY Change -89.13% -10.65%
NET CHANGE
Cash From Operating Activities 88.01K 734.7K
Cash From Investing Activities 0.000
Cash From Financing Activities -80.58K -741.6K
Net Change In Cash 7.437K -6.912K
YoY Change -207.6% -93.72%
FREE CASH FLOW
Cash From Operating Activities $88.01K $734.7K
Capital Expenditures $0.00
Free Cash Flow $734.7K
YoY Change 2.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1288040
CY2018Q4 us-gaap Goodwill
Goodwill
2905089
CY2018Q4 us-gaap Assets
Assets
22172851
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2712919
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2784271
CY2018Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
150000
CY2018Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1477448
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7124638
CY2018Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
13581529
CY2018Q4 us-gaap Liabilities
Liabilities
20706167
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
714891
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1267685
CY2019Q1 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
13581529
CY2019Q1 us-gaap Liabilities
Liabilities
19000335
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
244407
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74600181
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
714891
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
751793
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1466684
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22172851
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
667963
CY2019Q1 fzmd Allowance For Inventories Current
AllowanceForInventoriesCurrent
1741315
CY2018Q4 fzmd Allowance For Inventories Current
AllowanceForInventoriesCurrent
1711871
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
74600181
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71489066
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71489066
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2364168
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2195933
CY2019Q1 fzmd Commissions
Commissions
1005531
CY2018Q1 fzmd Commissions
Commissions
1579186
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25724
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2079
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
3777198
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-896652
CY2018Q1 us-gaap Interest Expense
InterestExpense
35905
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-197590
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-734967
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68737473
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28356561
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-510998
CY2018Q1 us-gaap Profit Loss
ProfitLoss
-734967
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
244407
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
138086
CY2019Q1 fzmd Provision For Bad Debts And Discounts
ProvisionForBadDebtsAndDiscounts
164642
CY2018Q1 fzmd Provision For Bad Debts And Discounts
ProvisionForBadDebtsAndDiscounts
-247125
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-125028
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-208392
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1841061
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2108429
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-76126
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-373509
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2665
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1709
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1194504
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1053654
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-430751
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
354982
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
88014
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
734656
CY2019Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-80577
CY2018Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-741568
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-80577
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-741568
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7437
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6912
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
804715
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
797803
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
20756
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
29698
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M18D
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y8M12D
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
443000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
417000
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
417000
CY2018Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
760993
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
760993
CY2018 fzmd Increase Decrease In Deferred Tax Asset
IncreaseDecreaseInDeferredTaxAsset
125028
CY2019Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1069434
CY2019Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in accordance with GAAP, requires the Company&#8217;s management to make</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">estimates and assumptions that affect the Company&#8217;s reported amounts in the consolidated financial statements. Actual results could</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">differ from those estimates. Significant estimates on the accompanying consolidated financial statements include the valuation of</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">inventories, the Company&#8217;s effective income tax rate, and the recoverability of deferred tax assets, which are based upon the</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company&#8217;s management expectation of future taxable income and allowable deductions and the fair value calculations of stock-based compensation and earn-out (&#8220;<font style="font-weight:bold;">Earn-Out</font>&#8221;) liability. </p>
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.69
CY2019Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
10482
CY2019Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassification</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain amounts in the accompanying unaudited condensed consolidated statements of operations have been reclassified to conform to the current presentation. State income tax expense has been reclassified from selling, general, administrative and other expenses to income tax expense (benefit).</p>
CY2019Q1 fzmd Net Operating Loss Carryforwards Earliest Expiration Year
NetOperatingLossCarryforwardsEarliestExpirationYear
2019
CY2019Q1 fzmd Net Operating Loss Carryforwards Latest Expiration Year
NetOperatingLossCarryforwardsLatestExpirationYear
2037
CY2019Q1 us-gaap Open Tax Year
OpenTaxYear
2016 2017 2018
CY2018Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
10802
CY2019Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10482
CY2018Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10802
CY2019Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-125028
CY2018Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-208392
CY2019Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2018Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.013
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.011
CY2019Q1 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.006
CY2019Q1 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-125028
CY2018Q1 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-208392
CY2019Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
224581
CY2019Q1 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
174847
CY2019Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
284119
CY2019Q1 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
391576
CY2019Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
33259
CY2019Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1108382
CY2019Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
218427
CY2019Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3934
CY2018Q1 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.006
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.008
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.000
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.183
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.193
CY2019Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
222361
CY2019Q1 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
886021
CY2019Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
886021
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
216793
CY2018Q4 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
140272
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
232793
CY2018Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
383744
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
28128
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1001730
CY2018Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
232835
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
7902
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
240737
CY2019Q1 fzmd Percentage Of Common Stock Issued
PercentageOfCommonStockIssued
0.614
CY2019Q1 fzmd Percentage Of Common Stock Outstanding
PercentageOfCommonStockOutstanding
0.614
CY2019Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
820650
CY2018 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-5663014
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
19244543
CY2019Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2019Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2019Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
351303
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
322693
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20355
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
68800
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
68800
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31195
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25826
CY2019Q1 us-gaap Depreciation
Depreciation
5369
CY2018Q1 us-gaap Depreciation
Depreciation
2079
CY2019Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
6658
CY2018Q1 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
6658
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3915000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
900000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4815000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1700000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.78
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.75
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.78
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.42
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y

Files In Submission

Name View Source Status
0001564590-19-016370-index-headers.html Edgar Link pending
0001564590-19-016370-index.html Edgar Link pending
0001564590-19-016370.txt Edgar Link pending
0001564590-19-016370-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fzmd-10q_20190331.htm Edgar Link pending
fzmd-20190331.xml Edgar Link completed
fzmd-20190331.xsd Edgar Link pending
fzmd-20190331_cal.xml Edgar Link unprocessable
fzmd-20190331_def.xml Edgar Link unprocessable
fzmd-20190331_lab.xml Edgar Link unprocessable
fzmd-20190331_pre.xml Edgar Link unprocessable
fzmd-ex311_8.htm Edgar Link pending
fzmd-ex312_6.htm Edgar Link pending
fzmd-ex321_7.htm Edgar Link pending
gm3o1anulhgh000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending